| Lastest Insider Transactions Of Atea Pharmaceuticals, Inc. ( AVIR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | 2026-03-11 | Option Exercise | 60,000 | 1.24 | 74,400 | 2026-03-13 18:00:09 |
| AVIR | Atea Pharmaceuticals, Inc. | Horga Maria Arantxa | Chief Medical Officer | 2026-01-31 | Option Exercise | 51,283 | 0.00 | 0 | 2026-02-03 19:53:00 |
| AVIR | Atea Pharmaceuticals, Inc. | Vavricka John | Chief Commercial Officer | 2026-01-31 | Option Exercise | 42,083 | 0.00 | 0 | 2026-02-03 19:47:27 |
| AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Officer | 2026-01-31 | Option Exercise | 58,050 | 0.00 | 0 | 2026-02-03 19:46:49 |
| AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | 2026-01-31 | Option Exercise | 54,866 | 0.00 | 0 | 2026-02-03 19:46:35 |
| AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | President, CEO, and Chairman | 2026-01-31 | Option Exercise | 572,983 | 0.65 | 372,000 | 2026-02-03 19:46:07 |
| AVIR | Atea Pharmaceuticals, Inc. | Foster Wayne | EVP, Chief Accounting Officer | 2026-01-31 | Option Exercise | 41,333 | 0.00 | 0 | 2026-02-03 19:42:48 |
| AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Directior | 2025-06-20 | Option Exercise | 29,600 | 0.00 | 0 | 2025-06-24 18:05:11 |
| AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Directior | 2025-06-20 | Option Exercise | 29,600 | 0.00 | 0 | 2025-06-24 18:05:09 |
| AVIR | Atea Pharmaceuticals, Inc. | Duncan Barbara Gayle | Directior | 2025-06-20 | Option Exercise | 29,600 | 0.00 | 0 | 2025-06-24 18:05:09 |
| AVIR | Atea Pharmaceuticals, Inc. | Polsky Bruce | Directior | 2025-06-20 | Option Exercise | 29,600 | 0.00 | 0 | 2025-06-24 18:05:07 |
| AVIR | Atea Pharmaceuticals, Inc. | Adams Jerome M. | Directior | 2025-06-20 | Option Exercise | 29,600 | 0.00 | 0 | 2025-06-24 18:05:06 |
| AVIR | Atea Pharmaceuticals, Inc. | Lucidi Bruno | Directior | 2025-06-20 | Option Exercise | 29,600 | 0.00 | 0 | 2025-06-24 18:05:05 |
| AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Officer | 2025-01-31 | Option Exercise | 46,800 | 0.00 | 0 | 2025-02-04 18:00:21 |
| AVIR | Atea Pharmaceuticals, Inc. | Vavricka John | Chief Commercial Officer | 2025-01-31 | Option Exercise | 33,333 | 0.00 | 0 | 2025-02-04 18:00:20 |
| AVIR | Atea Pharmaceuticals, Inc. | Horga Maria Arantxa | Chief Medical Officer | 2025-01-31 | Option Exercise | 41,533 | 0.00 | 0 | 2025-02-04 18:00:17 |
| AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | 2025-01-31 | Option Exercise | 44,367 | 0.00 | 0 | 2025-02-04 18:00:15 |
| AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | President, CEO, and Chairman | 2025-01-31 | Option Exercise | 173,467 | 0.00 | 0 | 2025-02-04 18:00:09 |
| AVIR | Atea Pharmaceuticals, Inc. | Foster Wayne | EVP, Chief Accounting Officer | 2025-01-31 | Option Exercise | 33,333 | 0.00 | 0 | 2025-02-04 18:00:06 |
| AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Directior | 2025-01-15 | Buy | 25,000 | 3.26 | 81,499 | 2025-01-17 14:30:36 |
| AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Directior | 2025-01-15 | Buy | 25,000 | 3.26 | 81,499 | 2025-01-17 08:03:19 |
| AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Directior | 2024-12-10 | Sell | 359,606 | 2.85 | 1,023,475 | 2024-12-12 18:00:03 |
| AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | President, CEO, and Chairman | 2024-09-17 | Sell | 57,969 | 4.04 | 234,155 | 2024-09-19 20:02:31 |
| AVIR | Atea Pharmaceuticals, Inc. | Polsky Bruce | Directior | 2024-06-20 | Sell | 17,544 | 3.49 | 61,144 | 2024-06-21 17:59:55 |
| AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Directior | 2024-06-16 | Option Exercise | 33,150 | 0.00 | 0 | 2024-06-18 17:00:14 |
| AVIR | Atea Pharmaceuticals, Inc. | Lucidi Bruno | Directior | 2024-06-16 | Option Exercise | 33,150 | 0.00 | 0 | 2024-06-18 17:00:13 |
| AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Directior | 2024-06-16 | Option Exercise | 33,150 | 0.00 | 0 | 2024-06-18 17:00:11 |
| AVIR | Atea Pharmaceuticals, Inc. | Polsky Bruce | Directior | 2024-06-16 | Option Exercise | 33,150 | 0.00 | 0 | 2024-06-18 17:00:09 |
| AVIR | Atea Pharmaceuticals, Inc. | Duncan Barbara Gayle | Directior | 2024-06-16 | Option Exercise | 33,150 | 0.00 | 0 | 2024-06-18 17:00:07 |
| AVIR | Atea Pharmaceuticals, Inc. | Adams Jerome M. | Directior | 2024-06-16 | Option Exercise | 33,150 | 0.00 | 0 | 2024-06-18 17:00:05 |
| AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | President, CEO, and Chairman | 2024-06-05 | Sell | 1,006 | 4.00 | 4,024 | 2024-06-07 18:34:21 |
| AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | 2024-01-31 | Sell | 15,843 | 3.84 | 60,915 | 2024-02-02 21:31:35 |
| AVIR | Atea Pharmaceuticals, Inc. | Corcoran Andrea | See Remarks | 2024-01-31 | Option Exercise | 44,367 | 0.00 | 0 | 2024-02-02 21:31:35 |
| AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | President, CEO, and Chairman | 2024-01-31 | Sell | 56,910 | 3.85 | 218,819 | 2024-02-02 21:30:44 |
| AVIR | Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | President, CEO, and Chairman | 2024-01-31 | Option Exercise | 173,467 | 0.00 | 0 | 2024-02-02 21:30:44 |
| AVIR | Atea Pharmaceuticals, Inc. | Horga Maria Arantxa | Chief Medical Officer | 2024-01-31 | Sell | 15,870 | 3.84 | 60,963 | 2024-02-02 21:29:08 |
| AVIR | Atea Pharmaceuticals, Inc. | Horga Maria Arantxa | Chief Medical Officer | 2024-01-31 | Option Exercise | 41,534 | 0.00 | 0 | 2024-02-02 21:29:08 |
| AVIR | Atea Pharmaceuticals, Inc. | Foster Wayne | EVP, Chief Accounting Officer | 2024-01-31 | Sell | 12,477 | 3.84 | 47,904 | 2024-02-02 21:26:53 |
| AVIR | Atea Pharmaceuticals, Inc. | Foster Wayne | EVP, Chief Accounting Officer | 2024-01-31 | Option Exercise | 33,334 | 0.00 | 0 | 2024-02-02 21:26:53 |
| AVIR | Atea Pharmaceuticals, Inc. | Vavricka John | Chief Commercial Officer | 2024-01-31 | Sell | 11,819 | 3.84 | 45,420 | 2024-02-02 21:25:59 |
| AVIR | Atea Pharmaceuticals, Inc. | Vavricka John | Chief Commercial Officer | 2024-01-31 | Option Exercise | 33,334 | 0.00 | 0 | 2024-02-02 21:25:59 |
| AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Officer | 2024-01-31 | Sell | 14,029 | 3.84 | 53,913 | 2024-02-02 21:24:58 |
| AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Officer | 2024-01-31 | Option Exercise | 46,800 | 0.00 | 0 | 2024-02-02 21:24:58 |
